Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Harm Reduction in Male Patients Actively Using Anabolic Androgenic Steroids (AAS) and Performance-Enhancing Drugs (PEDs): a Review
Alex K Bonnecaze, Thomas N. O’Connor, Cynthia Burns
Journal of General Internal Medicine (2021) Vol. 36, Iss. 7, pp. 2055-2064
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The world's first anabolic‐androgenic steroid testing trial: A two‐phase pilot combining chemical analysis, results dissemination and community feedback
Timothy Piatkowski, Ross Coomber, Cameron Francis, et al.
Addiction (2025)
Open Access | Times Cited: 3
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 14
Navigating Risks and Reducing Harm: A Gendered Analysis of Anabolic–Androgenic Steroid Users Within the Risk Environment Framework
Timothy Piatkowski, Matthew Dunn
Contemporary Drug Problems (2024) Vol. 51, Iss. 2, pp. 111-128
Open Access | Times Cited: 12
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
The Enhanced Games or Enhancing Harm?
Andrew Richardson
Performance Enhancement & Health (2024) Vol. 12, Iss. 3, pp. 100285-100285
Open Access | Times Cited: 6
Anabolic-Androgenic Steroid Misuse: Mechanisms, Patterns of Misuse, User Typology, and Adverse Effects
Jack B. Ding, Marcus Z. Ng, Steven S. Huang, et al.
Journal of Sports Medicine (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 33
Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs
Letizia Paoli, Luke Cox
International Journal of Drug Policy (2023) Vol. 123, pp. 104246-104246
Open Access | Times Cited: 13
The Uses of Anabolic Androgenic Steroids Among Athletes; Its Positive and Negative Aspects- A Literature Review
Zhang Wen-bo, Yan Zhang
Journal of Multidisciplinary Healthcare (2023) Vol. Volume 16, pp. 4293-4305
Open Access | Times Cited: 13
Illegal and falsified medicines self-administrated in not approved post-cycle therapy after the cessation of anabolic-androgenic steroids – qualitative analysis
Agata Błażewicz, Magdalena Popławska, Beata Daniszewska, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Abusive use of anabolic androgenic steroids, male sexual dysfunction and infertility: an updated review
Rafael de Almeida Azevedo, Bruno Gualano, Thiago Afonso Teixeira, et al.
Frontiers in Toxicology (2024) Vol. 6
Open Access | Times Cited: 4
Development, dissemination and community response towards the first community notice regarding misrepresented illicit anabolic‐androgenic steroids in circulation in Australia
Timothy Piatkowski, Isabelle Volpe, R. Brien, et al.
Drug and Alcohol Review (2025)
Open Access
Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
Raphael Magnolini, Kuvinda Kossinna, Daniel Bjasch, et al.
Schweizerische medizinische Wochenschrift (2025) Vol. 155, Iss. 2, pp. 4225-4225
Open Access
Social Interest Data as a Proxy for Off-Label Performance-Enhancing Drug Use: Implications and Clinical Considerations
Philip A Holubeck, Andrew C Eksi, Kyle Gillett, et al.
Cureus (2024)
Open Access | Times Cited: 2
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare
Geoff Bates, Scott T.C. Shepherd, Jim McVeigh
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 6, pp. 630-635
Open Access | Times Cited: 16
‘Sustaining masculinity’: a scoping review of anabolic androgenic steroid use by older males
Evelyn Hearne, Amanda Atkinson, Ian D. Boardley, et al.
Drugs Education Prevention and Policy (2022) Vol. 31, Iss. 1, pp. 27-53
Open Access | Times Cited: 10
Exploring user narratives of self-medicated black market IPED use for therapeutic & wellbeing purposes
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 10, Iss. 2, pp. 100207-100207
Closed Access | Times Cited: 13
Two sides of the same coin: A qualitative exploration of experiential and perceptual factors which influence the clinical interaction between physicians and Anabolic-Androgenic Steroid using patients in the UK
Neha Prasad Ainsworth, Sam N. Thrower, Andrea Petróczi
Emerging Trends in Drugs Addictions and Health (2022) Vol. 2, pp. 100033-100033
Open Access | Times Cited: 9
Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users
Ingo Butzke, Samuel Iff, Michael Zitzmann, et al.
Praxis (2022) Vol. 111, Iss. 6, pp. e339-e344
Closed Access | Times Cited: 8
Exploring Anabolic Androgenic Steroid Use Among Cisgender Gay, Bisexual, and Queer Men
Eric Kutscher, Arslaan Arshed, Richard E. Greene, et al.
JAMA Network Open (2024) Vol. 7, Iss. 5, pp. e2411088-e2411088
Open Access | Times Cited: 1
Clomiphene citrate and optional human chorionic gonadotropin for treating male hypogonadism arising from long-term anabolic-androgenic steroid use—A pilot study
Hans Christian Bordado Henriksen, Anders Palmstrøm Jørgensen, Astrid Bjørnebekk, et al.
Performance Enhancement & Health (2024) Vol. 12, Iss. 3, pp. 100283-100283
Open Access | Times Cited: 1
Navigating non-medical androgen use: Towards a harm reduction paradigm
Diederik L. Smit, Tijs Verdegaal, Peter Bond, et al.
Performance Enhancement & Health (2024) Vol. 12, Iss. 4, pp. 100288-100288
Open Access | Times Cited: 1
Carnitine traffic and human fertility
Tiziano Mazza, Mariafrancesca Scalise, Lara Console, et al.
Biochemical Pharmacology (2024), pp. 116565-116565
Open Access | Times Cited: 1
Beiträge aus der Praxis zum Themenschwerpunkt „Maskulinitäten und Sucht“
Ingo Butzke, Samuel Iff
SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice (2024) Vol. 70, Iss. 6, pp. 331-345
Closed Access | Times Cited: 1
The criminal liability of health care professionals treating anabolic steroid users under the SpoPA
Dominique Diethelm, Gian Ege, Malte Christian Claussen, et al.
Sports Psychiatry (2022) Vol. 1, Iss. 4, pp. 157-166
Open Access | Times Cited: 6
Early Pharmacologic Approaches to Avert Anabolic Steroid-induced Male Infertility: A Narrative Review
André Rizzuti, Conrado Alvarenga, Gustavo Stocker, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 11, pp. e234-e241
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top